Pharmacokinetics of isradipine in patients with chronic liver disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF00278589.pdf
Reference26 articles.
1. Hof RP, Scholtysik G, Loutzenhiser R, Vuorela HJ, Neumann P (1984) PN 200-110, a new calcium antagonist: Electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol 6: 407?416
2. Handler CE, Sowton E (1984) Safety, tolerability and efficacy of PN 200-110, a new calcium antagonist in patients with angina and coronary heart disease. Eur J Clin Pharmacol 27: 415?417
3. Tse FLS, Jaffe JM (1987) Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in man. Eur J Clin Pharmacol 32: 361?365
4. Eichelbaum M, Echizen H (1984) Clinical pharmacology of calcium antagonists: A critical review. J Cardiovasc Pharmacol 6: S963-S967
5. Blaschke TF, Rubin PC (1979) Hepatic first-pass metabolism in liver disease. Clin Pharmacokinet 4: 423?432
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup;Clinical Toxicology;2021-02-08
2. Phenytoin Toxicity After Transjugular Intrahepatic Portosystemic Shunt (TIPS);The Journal of Emergency Medicine;2021-01
3. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations;Expert Opinion on Drug Metabolism & Toxicology;2019-12-11
4. Reduced Duodenal Cytochrome P450 3A Protein Expression and Catalytic Activity in Patients With Cirrhosis;Clinical Pharmacology & Therapeutics;2009-02-11
5. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts;Hepatology;2001-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3